Nutritional drink aims to cut surgery complications in colorectal cancer

NCT ID NCT06134440

Terminated Disease control Sponsor: Istituto Oncologico Veneto IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a nutritional drink called Impact Oral®, taken for 5 days before and after surgery, could reduce complications in colorectal cancer patients. The trial included 71 patients eligible for minimally invasive surgery. However, the study was terminated early, so the results are not complete.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Impact Oral® (oral nutritional supplement with immune-nutrients)
What this could lead to: If it worked, this could show that a simple nutritional drink helps reduce complications after colorectal cancer surgery.
What could go wrong: The trial was terminated early, so results are limited. It only included patients eligible for minimally invasive surgery, so findings may not apply to all colorectal cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL ADENOCARCINOMA

Contacts and locations

Locations

Istituto Oncologico Veneto IRCCS

Padova, 35128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.